Open AccessLarotrectinib (Vitrakvi®)
Author(s) -
Janelle E Mann
Publication year - 2019
Publication title -
oncology times
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000603944.40723.f3
Subject(s) - trk receptor , medicine , fusion gene , clinical trial , cancer , tyrosine kinase inhibitor , fusion protein , cancer research , oncology , neurotrophin , gene , receptor , biology , genetics , recombinant dna